Reid Laurence 4
4 · KalVista Pharmaceuticals, Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Reid Laurence
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-11-23+17,000→ 17,000 totalExercise: $10.07Exp: 2034-11-22→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The option vests over a 36 month period: 1/36th on December 25, 2024, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.